TITLE

Kit helps physicians, women work together to weigh HRT risks, benefits

AUTHOR(S)
Robinson, Alex
PUB. DATE
January 1997
SOURCE
CMAJ: Canadian Medical Association Journal;01/15/97, Vol. 156 Issue 2, p248
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Features `Making Choices: Hormones After Menopause,' a kit designed to help physicians and women work together to weigh the risks and benefits of hormone replacement therapy for menopause in Ottawa, Ontario. Decision aids for physicians in their discussion of therapies with patients; Description of the decision process; Order information.
ACCESSION #
9704191432

 

Related Articles

  • HRT may raise women's kidney stone risk.  // GP: General Practitioner;10/15/2010, p9 

    The article focuses on a study, published in the "Archives of Internal Medicine," on the impact of hormone replacement therapy (HRT) on a woman's health. A team of U.S.-based researchers analyzed data of postmenopausal women who underwent HRT and found that HRT may increase the risk of kidney...

  • Simplify Your Hormone Decision. Freinkel, Susan // Health (Time Inc. Health);Jun99, Vol. 13 Issue 5, p68 

    Provides suggestions for women when considering hormone replacement therapy. Importance of weighing the risks against benefits; Advantages and disadvantages of estrogen supplements during the menopausal stage; Benefits of Raloxifene, which is approved by the United States Food and Drug...

  • Osteoporosis and bone densitometry: Does the emperor have clothes? Lentle, Brian C. // CMAJ: Canadian Medical Association Journal;11/17/98, Vol. 159 Issue 10, p1261 

    Discusses research regarding the use of bone densitometry in the treatment of postmenopausal osteoporosis. Research in this issue by Papaioannou et al; Influence of bone densitometry on women's decision to pursue hormone replacement therapy; Alternative use of nonhormonal medication such as...

  • Abusing patients by denying them choice. Smith, Richard // BMJ: British Medical Journal (International Edition);2/14/2004, Vol. 328 Issue 7436, p356 

    Discusses how denying patients decision making rights in making medical decisions is a form of abuse. Details of a paper from six years ago on patient choice in screening for colorectal cancer; Medical risks from hormone replacement therapy on menopausal women; Results of experiments on patient...

  • Decisions in prescribing HRT. Saunders, Carol S. // Patient Care for the Nurse Practitioner;May2001, Vol. 4 Issue 5, p45 

    Discusses the topics on hormone replacement therapy (HRT) which should be discussed by nurse practitioners during menopause counseling. Indications and contraindications of HRT; Comparison of the outcomes of estrogen and progestin replacement therapies; Route of administration. INSET: HRT...

  • Education helps women decide about hormone replacement therapy.  // American Family Physician;6/1/1996, Vol. 53 Issue 8, p2647 

    Reports on a study presented at the 23rd annual meeting of the North American Primary Care Research Group which evaluated the usefulness of educational aids in women's decision on hormone replacement therapy. Reduced decision uncertainty, improved comprehension as a few of the benefits from...

  • A complex question of odds: Hormones vs. no treatment.  // HealthFacts;Jan93, Vol. 18 Issue 164, p1 

    Discusses some of the existing research on the use of postmenopausal hormones. The issue of estrogen usage and risk of breast and uterine cancer and stroke; Reasons for changes in prescribing practices; Criticisms of the existing research; The risk assessment analysis published in the December...

  • The Premarin predicament. Pascoe, Elaine // Practical Horseman;Apr99, Vol. 27 Issue 4, p52 

    Discusses the controversy surrounding Premarin, a brand-name drug extracted from pregnant mares' urine used as a hormone-replacement therapy for menopausal women. Benefits of estrogen; Information on hormone-replacement therapy; Availability of other estrogen products; Information on herbal and...

  • The PMU controversy.  // Practical Horseman;Apr99, Vol. 27 Issue 4, p55 

    Focuses on the growth in the ranching business in North America due to the demand for Premarin, an estrogen product extracted from pregnant mares' urine used as a hormone replacement therapy for menopause. Ranches' adoption of a code of practice for horse care in response to public criticisms...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics